Sunshine Biopharma (SBFM) said Thursday it has raised about $2.5 million following the close of its registered direct offering of shares and pre-funded warrants to institutional investors.
The company said it will use the proceeds for general corporate purposes and working capital. Aegis Capital Corp. was the placement agent for the offering.
Price: 2.01, Change: -0.24, Percent Change: -10.76